<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">For the locally advanced gastric cancer, without non-curative factors, the most widely accepted therapies are neoadjuvant chemotherapy and radical gastrectomy plus D2 lymphadenectomy followed by adjuvant chemotherapy. Based on the seed and soil theory, peritoneal metastasis is defined as the implantation and progression of cancer cells seeded on peritoneum [
 <xref ref-type="bibr" rid="CR14">14</xref>–
 <xref ref-type="bibr" rid="CR16">16</xref>]. Studies have demonstrated that peritoneal micro-metastasis was detected in 5–20.5% of patients with locally advanced gastric cancer [
 <xref ref-type="bibr" rid="CR17">17</xref>–
 <xref ref-type="bibr" rid="CR19">19</xref>]. Serosal invasion in gastric cancer was positively correlated with positive peritoneal wash cytology, which was thought to be the early stage of macroscopic peritoneal metastasis [
 <xref ref-type="bibr" rid="CR20">20</xref>, 
 <xref ref-type="bibr" rid="CR21">21</xref>]. After radical surgery, 43–45.9% of gastric cancer patients will suffer from peritoneal recurrence [
 <xref ref-type="bibr" rid="CR22">22</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>].
</p>
